mTOR: from growth signal integration to cancer, diabetes and ageing

Cites (210)

Items 201–210 of 210

1. The Rapamycin-Binding Domain Governs Substrate Selectivity by the Mammalian Target of Rapamycin
   Lloyd P. McMahon, Kin Man Choi, Tai-An Lin, Robert T. Abraham, John C. Lawrence · 2002 · Molecular and Cellular Biology
2. Regulation of TSC2 by 14-3-3 Binding
   Yong Li, Ken Inoki, Raymond S. W. Yeung, Kun‐Liang Guan · 2002 · Journal of Biological Chemistry
3. Cdc42 Stimulates RNA Splicing via the S6 Kinase and a Novel S6 Kinase Target, the Nuclear Cap-binding Complex*
   Kristin F. Wilson, Wen-Jin Wu, R. Cerione · 2000 · Journal of Biological Chemistry
4. Efficient Tor Signaling Requires a Functional Class C Vps Protein Complex in Saccharomyces cerevisiae
   Sara A. Zurita-Martinez, Rekha Puria, Xuewen Pan, Jef D. Boeke, Maria Elena Cardenas · 2007 · Genetics
5. Rapamycin‐sensitive phase of 3T3‐L1 preadipocyte differentiation after clonal expansion
   AnneMarie Gagnon, Stephen Lau, Alexander Sorisky · 2001 · Journal of Cellular Physiology
6. Differential Requirement of mTOR in Postmitotic Tissues and Tumorigenesis
   Caterina Nardella, Arkaitz Carracedo, Andrea Alimonti, Robin M. Hobbs, John G. Clohessy, Zhenbang Chen, Ainara Egia, Alessandro Fornari, Michelangelo Fiorentino, Massimo F. Loda et al. · 2009 · Science Signaling
7. Nutritional control of gene expression in Drosophila larvae via TOR, Myc and a novel cis-regulatory element
   Ling Li, Bruce A. Edgar, Savraj Grewal · 2010 · BMC Cell Biology
8. TOR complex 2 is needed for cell cycle progression and anchorage-independent growth of MCF7 and PC3 tumor cells
   Ville Hietakangas, Stephen Michael Cohen · 2008 · BMC Cancer
9. HER2が増幅されPI3K3CAが変異した乳癌細胞におけるPI3K/mTor二重阻害剤NVP‐BEZ235による特異的アポトーシス誘発
   M Brachmann Saskia, Hofmann Irmgard, Schnell Christian · 2009
10. mTORC1 signals from late endosomes: Taking a TOR of the endocytic system
    Rory J. Flinn, Jonathan Backer · 2010 · Cell Cycle